New in MMWR: Mycoplasma pneumoniae, Carbapenem-Resistant Bacteria, and more

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]



MMWR banner

June 26, 2025

In this Issue

WEEKLY REPORT

The image shows the chest X-rays of a patient with Mycoplasma pneumoniae with text that reads, “Pediatric hospitalizations for M. pneumoniae pneumonia surged in Summer-Fall 2024. Consider testing in children of all ages during periods of high transmission. Use macrolides as first-line antibiotic treatment.”

Mycoplasma pneumoniae Infections in Hospitalized Children

The number of children with M. pneumoniae-associated community-acquired pneumonia (CAP) discharged from U.S. pediatric hospitals increased sharply in 2024, accounting for approximately half of hospitalized children with CAP in spring and summer.

  • Notes from the Field: Increase in New Delhi Metallo-β-Lactamase–Producing Carbapenem-Resistant Enterobacterales

    Enterobacterales, a type of gram-negative bacteria, can become resistant to broad-spectrum carbapenem antibiotics through production of carbapenemases. Although the most common carbapenemase in the United States is Klebsiella pneumoniae carbapenemase, New-Delhi metallo-β-lactamase, previously associated with returning international travelers, has become the most common carbapenemase in New York City. Providers should be aware of the trend and of predominant carbapenemases within their clinical settings when initiating antibiotic treatment of Enterobacterales infections.

  • Notes from the Field: Parvovirus B19 Activity

    After low rates during pandemic years (2021–2023), parvovirus B19 activity in 2024 exceeded pre-COVID-19 pandemic years. B19 test data for 2025 indicate further continued increase in transmission compared to 2024, particularly among people aged 10–14 and 15–44.

PDF of this issue (link)

Questions about this MMWR? Contact us at mmwrq@xxxxxxx

MOST READ THIS WEEK

CONTINUING EDUCATION

The figure is a photo of a group of young adults talking to each other. Text reads, “U.S. Selected Practice Recommendations for Contraceptive Use, 2024. From MMWR and Medscape. Get your free CE.”

New MMWR Medscape CE on U.S. Selected Practice Recommendations for Contraceptive Use, 2024

In Case You Missed It

The The image shows an illustration of a magnifying glass and text that reads, “In case you missed it.”shows the Centers for Disease Control and Prevention MMWR Recommendations & Reports logo on a purple background.

Notes from the Field: Assessment of Awareness, Use, and Access Barriers to Cooling Centers in Maricopa County, Arizona — August 1–September 15, 2023

In response to a survey distributed August 1 to September 14, 2023, 39% of cooling center visitors and 49% of the public reported lack of awareness of cooling centers as a barrier to using them.

Notes from the Field: HeatRisk Forecasts and Emergency Department Visits for Heat-Related Illness — New York, May–September 2024

The severity of the new HeatRisk forecast correlates with next-day heat-related emergency department visits in New York State.

U.S. Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  | 


[Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
  Powered by Linux